Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Harvard Business School
Johnson and Johnson
Baxter
Dow

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for HE3286

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug HE3286?

HE3286 is an investigational drug.

There have been 5 clinical trials for HE3286. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2008.

The most common disease conditions in clinical trials are Insulin Resistance, Diabetes Mellitus, and Ulcer. The leading clinical trial sponsors are Harbor Therapeutics and [disabled in preview].

Recent Clinical Trials for HE3286
TitleSponsorPhase
A Study of the Safety, Tolerance and Assessment of HE3286 on Insulin Sensitivity and Hepatic Glucose ProductionHarbor TherapeuticsPhase 1
Safety, Tolerance, Pharmacokinetics and Activity of HE3286 in Patients With Rheumatoid ArthritisHarbor TherapeuticsPhase 1/Phase 2
Safety, Tolerance and Activity of HE3286 in Patients With Type 2 Diabetes MellitusHarbor TherapeuticsPhase 2

See all HE3286 clinical trials

Clinical Trial Summary for HE3286

Top disease conditions for HE3286
Top clinical trial sponsors for HE3286

See all HE3286 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
Boehringer Ingelheim
AstraZeneca
Moodys
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.